Ertapenem
Ertapenem is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Complicated intra-abdominal infections
- Community-acquired pneumonia (CAP)
- Complicated urinary tract infections
- Complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis
- Elective colorectal surgical prophylaxis
- Acute pelvic infections (postpartum, septic abortion, and post-surgical gynecologic infections)
- Ertapenem is now FDA indicated in pediatrics (3 months-17 yo) for above indications
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Mild-moderate intra-abdominal infections (cholecystitis, cholangitis, diverticulitis, splenic and hepatic abscesses, peritonitis)
- Uncomplicated ESBL infections (e.g. UTIs, billiary tract infections)
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
INDICATIONS
FDA
FDA
- Complicated intra-abdominal infections
- Community-acquired pneumonia (CAP)
- Complicated urinary tract infections
- Complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis
- Elective colorectal surgical prophylaxis
- Acute pelvic infections (postpartum, septic abortion, and post-surgical gynecologic infections)
- Ertapenem is now FDA indicated in pediatrics (3 months-17 yo) for above indications
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Mild-moderate intra-abdominal infections (cholecystitis, cholangitis, diverticulitis, splenic and hepatic abscesses, peritonitis)
- Uncomplicated ESBL infections (e.g. UTIs, billiary tract infections)
There's more to see -- the rest of this entry is available only to subscribers.